Abstract
Aims
To assess the risk of adverse neonatal outcomes in women with gestational diabetes (GDM) by identifying subgroups of women at higher risk to recognize the characteristics most associated with an excess of risk.
Methods
Observational, retrospective, multicenter study involving consecutive women with GDM. To identify distinct and homogeneous subgroups of women at a higher risk, the RECursive Partitioning and AMalgamation (RECPAM) method was used. Overall, 2736 pregnancies complicated by GDM were analyzed. The main outcome measure was the occurrence of adverse neonatal outcomes in pregnancies complicated by GDM.
Results
Among study participants (median age 36.8 years, pre-gestational BMI 24.8 kg/m2), six miscarriages, one neonatal death, but no maternal death was recorded. The occurrence of the cumulative adverse outcome (OR 2.48, 95% CI 1.59–3.87), large for gestational age (OR 3.99, 95% CI 2.40–6.63), fetal malformation (OR 2.66, 95% CI 1.00–7.18), and respiratory distress (OR 4.33, 95% CI 1.33–14.12) was associated with previous macrosomia. Large for gestational age was also associated with obesity (OR 1.46, 95% CI 1.00–2.15). Small for gestational age was associated with first trimester glucose levels (OR 1.96, 95% CI 1.04–3.69). Neonatal hypoglycemia was associated with overweight (OR 1.52, 95% CI 1.02–2.27) and obesity (OR 1.62, 95% CI 1.04–2.51). The RECPAM analysis identified high-risk subgroups mainly characterized by high pre-pregnancy BMI (OR 1.68, 95% CI 1.21–2.33 for obese; OR 1.38 95% CI 1.03–1.87 for overweight).
Conclusions
A deep investigation on the factors associated with adverse neonatal outcomes requires a risk stratification. In particular, great attention must be paid to the prevention and treatment of obesity.
Similar content being viewed by others
References
American Diabetes Association (2015) Standards of medical care in diabetes 2015. Diabetes Care 38(suppl. 1):13–14
Mokkala K, Houttu N, Vahlberg T, Munukka E, Rönnemaa T, Laitinen K (2017) Gut microbiota aberrations precede diagnosis of gestational diabetes mellitus. Acta Diabetol 54:1147–1149
Clinical Management Guidelines for Obstetrician-Gynecologists (2001) ACOG practice bulletin no. 30. American College of Obstetricians and Gynecologists, Washington, DC
Buckley BS, Harreiter J, Damm P et al (2012) Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med 29:844–854
Lapolla A, Dalfra MG, Lencioni C, Di Cianni G (2004) Epidemiology of diabetes in pregnancy: a review of Italian data. Diabetes Nutr Metab 17:358–367
Casey BM, Lucas MJ, Mcintire DD, Leveno KJ (1997) Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 90:869–873
Hjalmarson O (1981) Epidemiology and classification of acute, neonatal respiratory disorders. A prospective study. Acta Paediatr Scand 70:773–783
Mills JL, Baker L, Goldman AS (1979) Malformations in infants of diabetic mothers occur before the seventh week. Implications for treatment. Diabetes 28:292–293
Person B, Hanson U (1998) Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 21(suppl 2):B79–B84
McFarland LV, Raskin M, Daling JR, Benedetti TJ (1986) Erb/Duchenne’s palsy: a consequence of fetal macrosomia and method of delivery. Obstet Gynecol 68:784–788
Watson D, Rowan J, Neale L, Battin MR (2003) Admissions to neonatal intensive care unit following pregnancies complicated by gestational or type 2 diabetes. Aust N Z J Obstet Gynaecol 43(6):429–432
Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 24:2477–2486
Landon MB, Spong CY, Thom E et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361:1339–1348
Reece EA, Leguizamo G, Wiznitzer A (2009) Gestational diabetes: the need for a common ground. Lancet 373:1789–1797
McKenzie-Sampson S, Paradis G, Healy-Profitós J, St-Pierre F, Auger N (2018) Gestational diabetes and risk of cardiovascular disease up to 25 years after pregnancy: a retrospective cohort study. Acta Diabetol 55:315–322
Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779
Goueslard K, Cottenet J, Mariet AS, Sagot P, Petit JM, Quantin C (2017) Early screening for type 2 diabetes following gestational diabetes mellitus in France: hardly any impact of the 2010 guidelines. Acta Diabetol 54:645–651
Burlina S, Dalfrà MG, Visentin S, Valentini R, Capovilla F, Lapolla A (2017) Training Experience Group. Team management of gestational diabetes: a training experience. Acta Diabetol 54:881–883
Metzger BE, Lowe LP, Dyer AR et al (2008) HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002
Metzger BE, Gabbe SG, Persson B et al (2010) International Association of Diabetes and Pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682
Corrado F, Pintaudi B, Di Vieste G et al (2014) Italian risk factor-based screening for gestational diabetes. J Matern Fetal Neonatal Med 27:1445–1448
Linea guida gravidanza fisiologica. Sistema Nazionale per le Linee Guida dell'Istituto Superiore di Sanità. http://www.salute.gov.it/imgs/C_17_pubblicazioni_1436_allegato.pdf. Accessed 20 April 2018
Ciampi A (1992) Constructing prediction trees from data: the RECPAM approach. In: Proceedings from the Prague 1991 summer school on computational aspects of model choice. Physica-Verlag, Heidelberg, pp 165–178
Franciosi M, Pellegrini F, De Berardis G et al (2005) Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med 22:900–906
Pintaudi B, Di Vieste G, Corrado F et al (2013) Improvement of selective screening strategy for gestational diabetes through a more accurate definition of high-risk groups. Eur J Endocrinol 170:87–93
Fadl HE, Ostlund IK, Magnuson AF, Hanson US (2010) Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabet Med 27:436–441
Shand AW, Bell JC, McElduff A, Morris J, Roberts CL (2008) Outcomes of pregnancies in women with pre-gestational diabetes mellitus and gestational diabetes mellitus; a population-based study in New South Wales, Australia, 1998–2002. Diabet Med 25:708–715
Beyerlein A, von Kries R, Hummel M et al (2010) Improvement in pregnancy-related outcomes in the offspring of diabetic mothers in Bavaria, Germany, during 1987–2007. Diabet Med 27:1379–1384
Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL (2014) Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996–2010. Diabetes Care 37:1590–1596
Lai FY, Johnson JA, Dover D, Kaul P (2016) Outcomes of singleton and twin pregnancies complicated by pre-existing diabetes and gestational diabetes: a population-based study in Alberta, Canada, 2005–11. J Diabetes 8:45–55
O’Sullivan EP, Avalos G, O’Reilly M, Dennedy MC, Gaffney G, Dunne F (2011) Atlantic DIP Collaborators. Atlantic Diabetes in pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 54(7):1670–1675
Devlieger R, Benhalima K, Damm P et al (2016) Maternal obesity in Europe: where do we stand and how to move forward? A scientific paper commissioned by the European Board and College of Obstetrics and Gynaecology (EBCOG). Eur J Obstet Gynecol Reprod Biol 201:203–208
Goldstein RF, Abell SK, Ranasinha S et al (2017) Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. JAMA 317:2207–2225
Santangeli L, Sattar N, Huda SS (2015) Impact of maternal obesity on perinatal and childhood outcomes. Best Pract Res Clin Obstet Gynaecol 29:438–448
Gaillard R, Durmuş B, Hofman A, Mackenbach JP, Steegers EA, Jaddoe VW (2013) Risk factors and outcomes of maternal obesity and excessive weight gain during pregnancy. Obesity (Silver Spring) 21:1046–1055
Catalano PM, McIntyre HD, Cruickshank JK et al (2012) The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35:780–786
Much D, Jaschinski H, Lack N et al (2016) Risk stratification in women with gestational diabetes according to and beyond current WHO criteria. Horm Metab Res 48:16–19
Parnell AS, Correa A, Reece EA (2017) Pre-pregnancy obesity as a modifier of gestational diabetes and birth defects associations: a systematic review. Matern Child Health J 21:1105–1120
Fuchs F, Bouyer J, Rozenberg P, Senat MV (2013) Adverse maternal outcomes associated with fetal macrosomia: what are the risk factors beyond birthweight? BMC Pregnancy Childbirth 13:90
Black MH, Sacks DA, Xiang AH, Lawrence JM (2010) Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values. Diabetes Care 33(12):2524–2530
Acknowledgements
The authors want to thank all the participating local study investigators. We thank the Italian Diabetes and Pregnancy AMD-SID study group for its support.
Author information
Authors and Affiliations
Consortia
Contributions
BP is the guarantor for the study. He had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Substantial contributions to conception and design, acquisition of data or analysis and interpretation of data: GL, RF, MD, ARD, EV, LS, CL, TM, AN, MB, AT, AN, BP. Drafting of the manuscript: BP, AN. Final approval of the version to be published: BP, RF, MD, ARD, EV, AT, LS, CL, TM, GL, AN, MB, AN. BP (the manuscript’s guarantor) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned have been explained.
Corresponding author
Ethics declarations
Conflict of interest
The author(s) declare that they have no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
For this type of study formal consent is not required.
Additional information
Managed by Antonio Secchi.
The members of the STRONG Study Collaborators are listed in Supplementary Appendix.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Pintaudi, B., Fresa, R., Dalfrà, M. et al. The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study. Acta Diabetol 55, 1261–1273 (2018). https://doi.org/10.1007/s00592-018-1208-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-018-1208-x